FLORHAM PARK, NJ -- (MARKET WIRE) -- March 06, 2007 -- QUMAS, a leading provider of quality management and regulatory affairs solutions, today announced that Neurogen Corporation (NASDAQ: NRGN) has selected the new QUMAS R&D Suite™ for its content management needs for Nonclinical, Clinical, CMC, Safety, Quality and Regulatory groups.
